TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial.

Yihebali Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.